Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06922643
What this trial is testing

Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital

Who this might be right for
Chronic Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 100
Testing effectiveness (Phase 2)Study completedNCT01435226
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 170
Testing effectiveness (Phase 2)Study completedNCT00953589
What this trial is testing

480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 74
Post-approval studies (Phase 4)Study completedNCT02902120
What this trial is testing

HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant

Who this might be right for
Hepatitis CRenal Insufficiency, ChronicDisorder of Transplanted Kidney
University of Maryland, Baltimore 21
Not applicableEnded earlyNCT02315638
What this trial is testing

Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Early research (Phase 1)Study completedNCT00749138
What this trial is testing

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

Who this might be right for
Chronic Hepatitis C
Bader, Ted, M.D. 18
Large-scale testing (Phase 3)Study completedNCT00910624
What this trial is testing

Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 168
Not applicableEnded earlyNCT00843076
What this trial is testing

Impact of Hepatitis C Virus Variability on Steatosis

Who this might be right for
Chronic Hepatitis C
University Hospital, Tours 27
Post-approval studies (Phase 4)Study completedNCT01378104
What this trial is testing

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Who this might be right for
Sustained Virologic ResponseIL28B Polymorphism
The Catholic University of Korea 178
Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT01965535
What this trial is testing

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 155
Not applicableStudy completedNCT02068963
What this trial is testing

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

Who this might be right for
Hepatitis C
Hologic, Inc. 352
Large-scale testing (Phase 3)Study completedNCT00104052
What this trial is testing

Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 107
Early research (Phase 1)Ended earlyNCT00439959
What this trial is testing

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

Who this might be right for
Hepatitis C, ChronicHepatitis C
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Ended earlyNCT01384383
What this trial is testing

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 248
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Post-approval studies (Phase 4)Study completedNCT00948220
What this trial is testing

Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm 26
Not applicableStudy completedNCT02601820
What this trial is testing

The Patient-Reported Outcomes Project of HCV-TARGET

Who this might be right for
Hepatitis C, ChronicLiver Diseases
University of North Carolina, Chapel Hill 1,601
Large-scale testing (Phase 3)Study completedNCT02973503
What this trial is testing

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis

Who this might be right for
Chronic HCV Infection
University Hospital, Clermont-Ferrand 117
Large-scale testing (Phase 3)Study completedNCT00363259
What this trial is testing

Pegintron Induction Therapy in HCV Non-Responders

Who this might be right for
Hepatitis C
Foundation for Liver Research 110
Next Page